Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.50
+0.65 (5.49%)
Apr 29, 2026, 1:12 PM EDT - Market open
Kazia Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 69.46 | 4.35 | 1.66 | 5.24 | 7.36 | 27.59 | Upgrade
|
| Cash & Short-Term Investments | 69.46 | 4.35 | 1.66 | 5.24 | 7.36 | 27.59 | Upgrade
|
| Cash Growth | 2166.74% | 162.22% | -68.38% | -28.80% | -73.32% | 214.77% | Upgrade
|
| Accounts Receivable | - | - | - | 0 | - | - | Upgrade
|
| Other Receivables | 0.31 | 0.09 | 0.13 | 0.1 | 0.05 | 0.08 | Upgrade
|
| Receivables | 0.31 | 0.09 | 0.13 | 0.11 | 0.05 | 0.08 | Upgrade
|
| Prepaid Expenses | 0.21 | 0.49 | 0.59 | 1.63 | 2 | 1.72 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 3.76 | 3.79 | 0.04 | 0.01 | Upgrade
|
| Total Current Assets | 69.99 | 4.93 | 6.15 | 10.77 | 9.45 | 29.39 | Upgrade
|
| Other Intangible Assets | 1.09 | 1.09 | 15.4 | 17.27 | 19.14 | 22 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.04 | 7.3 | 6.69 | Upgrade
|
| Total Assets | 71.11 | 6.06 | 21.59 | 28.08 | 35.89 | 58.09 | Upgrade
|
| Accounts Payable | 6.13 | 5.65 | 4.55 | 0.86 | 1.52 | 1.89 | Upgrade
|
| Accrued Expenses | 3.97 | 4.86 | 10.88 | 4.16 | 2.6 | 3.27 | Upgrade
|
| Short-Term Debt | 0.1 | 0.4 | 0.63 | 1.8 | 1.84 | - | Upgrade
|
| Other Current Liabilities | 14.18 | 3.15 | 9.73 | 0.75 | 0.76 | 3.16 | Upgrade
|
| Total Current Liabilities | 24.37 | 14.05 | 25.8 | 7.57 | 6.73 | 8.33 | Upgrade
|
| Pension & Post-Retirement Benefits | 0 | 0.04 | 0.04 | 0.06 | 0.12 | 0.05 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.27 | 0.27 | 2.02 | 2.29 | 2.56 | 2.93 | Upgrade
|
| Other Long-Term Liabilities | - | - | 3.75 | 6.12 | 8.21 | 8.93 | Upgrade
|
| Total Liabilities | 24.65 | 14.36 | 31.6 | 16.03 | 17.61 | 20.24 | Upgrade
|
| Common Stock | 186.59 | 123.05 | 101.64 | 97.45 | 84.48 | 80.29 | Upgrade
|
| Retained Earnings | -145.61 | -134.83 | -115.13 | -89.08 | -68.62 | -44.2 | Upgrade
|
| Comprehensive Income & Other | 5.48 | 3.48 | 3.48 | 3.68 | 2.41 | 1.76 | Upgrade
|
| Total Common Equity | 46.47 | -8.3 | -10.02 | 12.05 | 18.27 | 37.85 | Upgrade
|
| Shareholders' Equity | 46.47 | -8.3 | -10.02 | 12.05 | 18.27 | 37.85 | Upgrade
|
| Total Liabilities & Equity | 71.11 | 6.06 | 21.59 | 28.08 | 35.89 | 58.09 | Upgrade
|
| Total Debt | 0.1 | 0.4 | 0.63 | 1.8 | 1.84 | - | Upgrade
|
| Net Cash (Debt) | 69.36 | 3.95 | 1.02 | 3.45 | 5.52 | 27.59 | Upgrade
|
| Net Cash Growth | 2272.48% | 286.02% | -70.30% | -37.59% | -79.99% | 214.77% | Upgrade
|
| Net Cash Per Share | 31.09 | 3.60 | 1.94 | 9.35 | 20.84 | 117.22 | Upgrade
|
| Filing Date Shares Outstanding | 11.34 | 1.83 | 0.87 | 0.47 | 0.3 | 0.26 | Upgrade
|
| Total Common Shares Outstanding | 11.34 | 1.62 | 0.67 | 0.46 | 0.28 | 0.26 | Upgrade
|
| Working Capital | 45.61 | -9.12 | -19.65 | 3.21 | 2.72 | 21.06 | Upgrade
|
| Book Value Per Share | 4.10 | -5.13 | -15.05 | 26.42 | 65.85 | 143.36 | Upgrade
|
| Tangible Book Value | 45.38 | -9.39 | -25.42 | -5.22 | -0.86 | 15.85 | Upgrade
|
| Tangible Book Value Per Share | 4.00 | -5.80 | -38.18 | -11.44 | -3.11 | 60.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.